Sponsor:
Barbara Ann Karmanos Cancer Institute
Code:
NCT00935090
Conditions
Brain and Central Nervous System Tumors
Chronic Myeloproliferative Disorders
Leukemia
Lymphoma
Lymphoproliferative Disorder
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
3'-deoxy-3'-[18F]fluorothymidine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-15. This information was provided to ClinicalTrials.gov by Barbara Ann Karmanos Cancer Institute on 2024-06-28.